A nurse recently administered filgrastim intravenously to a client who has cancer and is receiving cytotoxic chemotherapy. For which of the following data, discovered after the medication was administered, should the nurse file an incident report?
- The medication vial sat at room temperature for 2 hr before it was administered
- The nurse flushed the client's IV line with dextrose 5% in water before and after medication was administered.
- The client had chemotherapy 12 hr before the medication was administered
- The client's absolute neutrophil count was 2,500/mm3 before the medication was administered
